News
10h
MedPage Today on MSNDid FDA Pick the Wrong COVID Vaccine Strain Last Season?The researchers followed participants from October 2024 to January 2025. Median age was 76 years, and 54.2% were women. By ...
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...
Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...
Moderna, Inc.'s Q2 2025 earnings highlight a steep revenue decline post-pandemic, with just $0.1bn in revenue and a $(0.8bn) ...
CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...
Vinay Prasad is leaving Sensible Medicine to take a senior role at the US FDA. He has our enthusiastic support. Prasad is ...
Healthbeat on MSN18h
Sorting out Covid vaccine confusion: New and conflicting federal policies raise questionsIf you want a Covid-19 shot this fall, will your employer’s health insurance plan pay for it? There’s no clear answer. But ...
5h
Sportschosun on MSNCOVID-19 cases are on the rise...KCDA signs contract to procure 5.3 million doses of vaccine for 202...While the number of COVID-19 patients is on the rise, the Korea Centers for Disease Control and Prevention has signed a ...
SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the ...
Bird flu, for the moment, appears to be under control. But experts have a warning for federal and state health officials.
A strategy of selecting stocks based on rapid revenue growth has outperformed the broad market over the decades MarketWatch's Brett Arends covered research showing that a combination of looking back ...
Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results